Luteolin, a Potent Anticancer Compound : From Chemistry to Cellular Interactions and Synergetic Perspectives
(2022) In Cancers 14(21).- Abstract
Increasing rates of cancer incidence and the toxicity concerns of existing chemotherapeutic agents have intensified the research to explore more alternative routes to combat tumor. Luteolin, a flavone found in numerous fruits, vegetables, and herbs, has exhibited a number of biological activities, such as anticancer and anti-inflammatory. Luteolin inhibits tumor growth by targeting cellular processes such as apoptosis, cell-cycle progression, angiogenesis and migration. Mechanistically, luteolin causes cell death by downregulating Akt, PLK-1, cyclin-B1, cyclin-A, CDC-2, CDK-2, Bcl-2, and Bcl-xL, while upregulating BAX, caspase-3, and p21. It has also been reported to inhibit STAT3 signaling by the suppression of STAT3 activation and... (More)
Increasing rates of cancer incidence and the toxicity concerns of existing chemotherapeutic agents have intensified the research to explore more alternative routes to combat tumor. Luteolin, a flavone found in numerous fruits, vegetables, and herbs, has exhibited a number of biological activities, such as anticancer and anti-inflammatory. Luteolin inhibits tumor growth by targeting cellular processes such as apoptosis, cell-cycle progression, angiogenesis and migration. Mechanistically, luteolin causes cell death by downregulating Akt, PLK-1, cyclin-B1, cyclin-A, CDC-2, CDK-2, Bcl-2, and Bcl-xL, while upregulating BAX, caspase-3, and p21. It has also been reported to inhibit STAT3 signaling by the suppression of STAT3 activation and enhanced STAT3 protein degradation in various cancer cells. Therefore, extensive studies on the anticancer properties of luteolin reveal its promising role in chemoprevention. The present review describes all the possible cellular interactions of luteolin in cancer, along with its synergistic mode of action and nanodelivery insight.
(Less)
- author
- organization
- publishing date
- 2022-11
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- anti-inflammation, anti-metastasis, apoptosis and cell cycle, luteolin, synergistic action
- in
- Cancers
- volume
- 14
- issue
- 21
- article number
- 5373
- publisher
- MDPI AG
- external identifiers
-
- pmid:36358791
- scopus:85141719063
- ISSN
- 2072-6694
- DOI
- 10.3390/cancers14215373
- language
- English
- LU publication?
- yes
- id
- e5dc4626-bbca-48ee-a10e-d2b5b666d43f
- date added to LUP
- 2022-11-30 09:44:59
- date last changed
- 2024-09-19 04:18:36
@article{e5dc4626-bbca-48ee-a10e-d2b5b666d43f, abstract = {{<p>Increasing rates of cancer incidence and the toxicity concerns of existing chemotherapeutic agents have intensified the research to explore more alternative routes to combat tumor. Luteolin, a flavone found in numerous fruits, vegetables, and herbs, has exhibited a number of biological activities, such as anticancer and anti-inflammatory. Luteolin inhibits tumor growth by targeting cellular processes such as apoptosis, cell-cycle progression, angiogenesis and migration. Mechanistically, luteolin causes cell death by downregulating Akt, PLK-1, cyclin-B1, cyclin-A, CDC-2, CDK-2, Bcl-2, and Bcl-xL, while upregulating BAX, caspase-3, and p21. It has also been reported to inhibit STAT3 signaling by the suppression of STAT3 activation and enhanced STAT3 protein degradation in various cancer cells. Therefore, extensive studies on the anticancer properties of luteolin reveal its promising role in chemoprevention. The present review describes all the possible cellular interactions of luteolin in cancer, along with its synergistic mode of action and nanodelivery insight.</p>}}, author = {{Singh Tuli, Hardeep and Rath, Prangya and Chauhan, Abhishek and Sak, Katrin and Aggarwal, Diwakar and Choudhary, Renuka and Sharma, Ujjawal and Vashishth, Kanupriya and Sharma, Sheetu and Kumar, Manoj and Yadav, Vikas and Singh, Tejveer and Yerer, Mukerrem Betul and Haque, Shafiul}}, issn = {{2072-6694}}, keywords = {{anti-inflammation; anti-metastasis; apoptosis and cell cycle; luteolin; synergistic action}}, language = {{eng}}, number = {{21}}, publisher = {{MDPI AG}}, series = {{Cancers}}, title = {{Luteolin, a Potent Anticancer Compound : From Chemistry to Cellular Interactions and Synergetic Perspectives}}, url = {{http://dx.doi.org/10.3390/cancers14215373}}, doi = {{10.3390/cancers14215373}}, volume = {{14}}, year = {{2022}}, }